Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference

Addex Therapeutics announced that Tim Dyer, Chief Executive Officer, will be attending the H.C. Wainwright 25th Annual Global Investment Conference in New York.

Scroll to Top